NIIN Output Data
NIIN:
NSN:
Item Name:
CEFOXITIN FOR INJECTION , USP
Definition:
Reference/Part Number
| Part Number | CAGE | Status | RNCC | RNVC | DAC | RNAAC | MSDS | SADC |
|---|---|---|---|---|---|---|---|---|
| 3357 | 06990 | A | 3 | 1 | 6 | 54 | ||
| NDC00006-3357-53 | 06990 | A | 3 | 2 | 6 | 54 | ||
| NDC59911-5964-02 | 04CB7 | F | 5 | 9 | 4 | ZZ | ||
| MEFOXIN | 06990 | A | 5 | 1 | 6 | 54 | ||
| NDC63323-0342-20 | 1DQP2 | A | 5 | 2 | 4 | ZZ | ||
| NDC63323-0342-20 | 4JRB5 | A | 3 | 2 | 4 | ZZ | ||
| NDC63323-0342-20 | 00E55 | A | 3 | 1 | 4 | ZZ |
CAGE Information
| Code | Company |
|---|---|
| 00E55 | CARDINAL HEALTH INC. DBA CARDINAL HE |
| 06990 | MERCK SHARP & DOHME CORP. DBA MERCK |
| 04CB7 | ESI LEDERLE GENERICS |
| 1DQP2 | AMERICAN PHARMACEUTICAL PARTNERS |
| 4JRB5 | APP PHARMACEUTICALS INC. |
Federal Supply Class
Title
DRUGS AND BIOLOGICALS
Inclusions:
INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.
Exclusions:
EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.
Characteristics (Decoded)
| MRC | Requirements Statement | Clear Text Reply |
|---|---|---|
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 2.000 GRAMS OF ACTIVE INGREDIENT |
| AGXW | PHYSICAL FORM | POWDER |
| CSGS | ADMINISTRATION | INTRAMUSCULAR OR INTRAVENOUS |
| CQCT | PRIMARY CONTAINER TYPE | VIAL |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | CEFOXITIN SODIUM STERILE USP 2GM VIAL 25S |
| FEAT | SPECIAL FEATURES | 20 ML. SIZE VIAL |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 2.000 GRAMS CEFOXITIN EQUIVALENT |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 25 |